IO BIOTECH ApS: Financial statements 2022
CVR: 36474483
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
IO BIOTECH ApS (CVR 36474483) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -463,037,029 compared with DKK -240,410,969 the year before. Equity in the 2022 report amounted to DKK 259,741,482. The solvency ratio was 62.3%. The company had 19 employees in the financial year.
- Profit/Loss
- DKK -463,037,029
- Equity
- DKK 259,741,482
- Total Assets
- DKK 417,027,734
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | -463 mio. | 259.7 mio. | 19 |
| 2021 | - | - | -240.4 mio. | 722.8 mio. | 15 |
| 2020 | - | - | -65.2 mio. | 17.5 mio. | - |
| 2019 | - | - | -68.7 mio. | -13.9 mio. | 12 |
| 2018 | - | - | -51.3 mio. | 54.8 mio. | 11 |
Official annual report
Keep an eye on IO BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of November 15, 2022, Christian Ellebæk Elling has left the board of directors of IO BIOTECH ApS.
As of November 15, 2022, Jack Bech Nielsen has left the board of directors of IO BIOTECH ApS.
As of November 15, 2022, Peter Hirth has left the board of directors of IO BIOTECH ApS.
As of November 15, 2022, Kathleen Sereda Glaub has left the board of directors of IO BIOTECH ApS.
As of November 15, 2022, Vanessa Malier has left the board of directors of IO BIOTECH ApS.
As of November 15, 2022, Priyanka Belawat has left the board of directors of IO BIOTECH ApS.
IO BIOTECH ApS has published its annual report for 2021. The net result was DKK -240,410,969.
As of May 25, 2022, Claus Asbjørn Andersson has left the board of directors of IO BIOTECH ApS.
As of May 25, 2022, Emmanuelle Coutanceau has left the board of directors of IO BIOTECH ApS.
About IO BIOTECH ApS
IO BIOTECH ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2014. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by IO Biotech Inc.. The company has 9 employees (2026). In 2024, the company reported a net result of EUR -84,833,635 compared with EUR -76,648,917 the year before. Equity in the 2024 report amounted to EUR -6,630,183.